PLEASANTON, Calif., August, 2014* — The Cooper Companies, Inc. (NYSE: COO) has completed its acquisition of Sauflon Pharmaceuticals Limited, the manufacturer and distributor of soft contact lenses and solutions. The transaction – valued at approximately $1.2 billion – gives CooperVision the ability to offer the most extensive range of daily disposable contact lens options to eye care practitioners and wearers worldwide.
“We’re approaching the daily disposables category with a new, multi-tier model. By adding the Sauflon portfolio to our already-strong MyDay® and Proclear® brand choices, we’re bringing forward multiple contact lens families designed and marketed for distinct wearer segments,” said Daniel G. McBride, president of CooperVision, Inc. “This approach to the market provides practitioners the ability to offer a daily disposable lens for every eye and every budget, which should further accelerate both practice growth and category momentum.”
The global daily disposable market has been growing at 10 percent – the fastest-expanding segment among soft contact lenses. Clariti® – now part of the CooperVision range – is the only brand of daily disposable silicone hydrogel lenses that spans the entire vision correction spectrum (sphere, toric and multifocal), offering strong performance and cost benefits. The line complements CooperVision’s premium MyDay lens – which is now being launched in markets beyond Europe – as well as its Proclear 1 day lens with one-of-a-kind PC Technology™.
Continued Mr. McBride, “The Sauflon acquisition is one further component in our commitment to be the best possible business partner for eye care practitioners around the world. This goes beyond providing innovative products, services and support. Our teams are stepping up to help customers better capitalize on new market opportunities such as the migration to daily disposable wear.”
CooperVision is now working to combine both companies’ people, processes and pipelines to build the best possible customer and wearer experience. Customers should continue working with their current CooperVision and Sauflon representatives, support resources and ordering mechanisms until
About The Cooper Companies
The Cooper Companies, Inc. (“Cooper”) is a global medical device company publicly traded on the NYSE
Euronext (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical focuses on supplying women’s health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. Headquartered in Pleasanton, Calif., Cooper has approximately 9,000 employees with products
sold in over 100 countries. For more information, please visit www.coopercos.com.
About CooperVision, Inc.
CooperVision, a unit of The Cooper Companies, Inc. (NYSE:COO), is one of the world’s leading manufacturers of soft contact lenses. The Company produces a full array of daily disposable, two-week and monthly contact lenses, all featuring advanced materials and optics. CooperVision has a strong heritage of solving the toughest vision challenges such as astigmatism and presbyopia; and offers the most complete collection of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.